Investor Welcome

Clinigen was admitted to London's Alternative Investment Market (AIM) in September 2012.

The information disclosed in the investor's section is in accordance with AIM Rule 26.

We welcome our new shareholders and aim to keep them informed of our objectives, strategy and performance.

Share Price

460.00p   -9.75p   -2.08%
as at 16 September 2014